Platelet Dynamics in Hepatocellular Carcinoma
Summary
Platelets, traditionally recognised for their role in haemostasis, are now understood to influence the initiation, progression and therapeutic response of hepatocellular carcinoma (HCC). Within the hepatic tumour microenvironment, platelets interact with cancer cells, stromal components and immune infiltrates, releasing growth factors and cytokines that promote angiogenesis, matrix remodelling and immunomodulation. Hypoxic gradients typical of HCC lesions further stimulate platelet activation, driving invasive phenotypes and recurrence. Conversely, low platelet counts or thrombocytopenia often correlate with advanced cirrhosis, altered vascular architecture and poorer overall survival. Emerging technologies, including patient‐derived tumour chips that recapitulate oxygen heterogeneity, shed light on how platelet behaviour adapts to microenvironmental cues and influences drug sensitivity. This duality positions platelets as both biomarkers for prognosis and potential targets for adjuvant therapy, underlining their global significance in HCC management.
Research from Nature Portfolio
A microfluidic tumour‐on‐a‐chip study has modelled the dual hepatic blood supply and associated oxygen gradients to dissect platelet–tumour interactions under normoxic and hypoxic conditions. By culturing patient‐derived HCC slices on a chip with perpendicular drug and oxygen gradients, investigators demonstrated that hypoxia‐exposed cancer cells exhibit heightened invasiveness and platelet‐mediated resistance to standard agents. Implantation of these chips into murine xenografts validated that platelet‐associated secretomes under low-oxygen tension predict recurrence risk. This platform offers a personalised approach to evaluating antiplatelet and chemotherapeutic combinations.
Platelet Dynamics in Hepatocellular Carcinoma publication trend
The graph below shows the total number of articles in platelet dynamics in hepatocellular carcinoma across all publications each year (not limited to Nature Index journals).
Technical terms
Platelet: Small, anucleate blood cell fragment that mediates clotting and releases bioactive molecules influencing cancer cell behaviour.
Tumour microenvironment: The complex milieu of cancer cells, immune cells, stromal elements and extracellular matrix surrounding a tumour.
Hypoxia: A condition of reduced oxygen availability within tissues, driving adaptive responses in cancer and platelets.
Thrombocytopenia: A state of abnormally low platelet count often seen in advanced liver disease and linked to poorer prognosis.
Nomogram: A graphical predictive tool that integrates multiple clinical variables to estimate individual patient risk.
Mendelian randomisation: A genetic epidemiology method using inherited variants as proxies to assess causal effects of modifiable exposures.
References
- Chip collection of hepatocellular carcinoma based on O2 heterogeneity from patient tissue. Nature Communications (2024).
- Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter. Frontiers in Pharmacology (2025).
- Causal associations between platelet count, alcohol consumption, and the risk of liver hepatocellular carcinoma based on a Mendelian randomization study. Frontiers in Endocrinology (2024).
- Impact of Thrombocytopenia on Survival in Patients with Hepatocellular Carcinoma: Updated Meta-Analysis and Systematic Review. Cancers (2024).
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.